Updated Treatment of Fibromyalgia Syndrome: A Review

Author:

Ibrahim Ahmed Abdulaziz G.,AlMutairi Mazyad Hamed M.,ALMutairi Abeer Fahad M.,Alharbi Wejdan Alhumaidi A.,Almadi Ebtesam Ali S.,Alwabisi Shoog Abdullah O.,Albalawi Nashwa Zead A.,Alanazi Hamdah Hnef S.,Althobaiti Alanoud Abdullah H.,Alkhathami Amirah Ali M.,Alamrani Amani Salem K.,Altemani Omniah Salem D.,Mohammedsaleh Maani Mahmoud A.,Aljuhani Arwa Mohammed Alrefai,Alrashidi Rinad Rasheed M

Abstract

Fibromyalgia is a debilitating condition that is frequently misdiagnosed. It affects 2% of the population, with middle-aged women having the highest frequency. Fibromyalgia affects more women than men, and It becomes worse as you get older. Because medical treatment for fibromyalgia is typically only partial, health professionals must provide patients with ongoing assistance in order for them to become effective, active self-managers. There is no one-size-fits-all drug for fibromyalgia, but you do have a lot of options for treating your symptoms. However, Antidepressants in general such as “duloxetine” and Gabapentinoids drugs such as “pregabline” are the most used drugs. There is some evidence that NSAIDs may have a synergistic effect when combined with centrally active agents such as tricyclic antidepressants and anticonvulsants. Among non-pharmacological therapy, exercise and psychoeducational techniques have the most evidence of efficacy, but they must be personalized to the individual. In this review we will be looking at diagnosis and treatment of fibromyalgia.

Publisher

Sciencedomain International

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3